• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)

Publication
Article
Supplements and Featured PublicationsCurrent Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that has no established cure and is frequently fatal within 2 to 5 years as patients experience a rapid functional decline in their abilities to move, talk, swallow, and breathe. Current treatment options remain limited, but there is a pipeline of late-stage therapeutic options that could expand the treatment options for patients with ALS.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.